MOONLAKE IMMUNOTHERAPEUTICS

MLTXNASDAQ

🏆 #1933 by market capEarnings Nov 4US Equity

$17.23▲ $0.67 (+3.86%)

Live

1h—

24h▲ 3.9%

7d▼ 1.9%

14d▼ 6.3%

30d▼ 15.6%

1y▼ 68.6%

🏦Market Cap

$1.42B

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

59

Weak

Earnings

Q3 · 2026Reported 2026-08-10

Earnings Per Share

Actual

-0.84

Expected

-0.91

beat

+7.50%

YoY +3.40%

Revenue

Actual

—

Expected

—

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.84

beat

Q2 2026

-0.98

miss

Q1 2026

-0.92

inline

Q4 2025

-1.10

miss